Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer

BJU International

Volumn 114, Issue 6, 2014, Pages E18-E24

  Wang, Siao Yi ^a   Cowan, Janet E ^a   Clint Cary, K ^a   Chan, June M ^a   Carroll, Peter R ^a   Cooperberg, Matthew R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

active surveillance; nomograms; prediction; progression; prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; AREA UNDER THE CURVE; ARTICLE; ASIAN; CANCER STAGING; CAUCASIAN; CHUN NOMOGRAM; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; DISEASE SURVEILLANCE; GLEASON SCORE; HISPANIC; HUMAN; HUMAN TISSUE; KATTAN BASE NOMOGRAM; KATTAN FULL NOMOGRAM; KATTAN MEDIUM NOMOGRAM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; NAKANISHI NOMOGRAM; NOMOGRAM; OUTCOME ASSESSMENT; PATIENT MONITORING; PREDICTION; PROBABILITY; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; STEYERBERG NOMOGRAM; CANCER GRADING; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROSTATIC NEOPLASMS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; VERY ELDERLY; WATCHFUL WAITING;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; DISEASE PROGRESSION; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; ROC CURVE; WATCHFUL WAITING;

EID: 84920138551     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12554     Document Type: Article

References (28)

1. Schroder FH, Hugosson J, Roobol MJ, etal. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328
2. Hugosson J, Carlsson S, Aus G, etal. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010; 11: 725-732
3. Esserman L, Shieh Y, Thompson I,. Rethinking screening for breast cancer and prostate cancer. JAMA 2009; 302: 1685-1692
4. Cooperberg MR, Carroll PR, Klotz L,. Active surveillance for prostate cancer: progress and promise. J Clin Oncol 2011; 29: 3669-3676
5. Suardi N, Capitanio U, Chun FK, etal. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer 2008; 113: 2068-2072
6. Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll PR,. Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol 2009; 181: 1628-1633; discussion 1633-4
7. Dong F, Kattan MW, Steyerberg EW, etal. Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice. J Urol 2008; 180: 150-154; discussion 154
8. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP,. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71 (3 Suppl.): 933-938
9. Kattan MW, Eastham JA, Wheeler TM, etal. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003; 170: 1792-1797
10. Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schroder FH,. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 2007; 177: 107-112; discussion 112
11. Nakanishi H, Wang X, Ochiai A, etal. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance. Cancer 2007; 110: 2441-2447
12. Chun FK, Haese A, Ahyai SA, etal. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. Cancer 2008; 113: 701-709
13. Epstein JI, Carmichael M, Partin AW, Walsh PC,. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993; 149: 1478-1481
14. Porten SP, Cooperberg MR, Carroll PR,. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease. BJU Int 2010; 105: 472-475
15. Nguyen CT, Kattan MW,. Formalized prediction of clinically significant prostate cancer: is it possible? Asian J Androl 2012; 14: 349-354
16. Epstein JI, Walsh PC, Carmichael M, Brendler CB,. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368-374
17. Zweig MH, Campbell G,. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577
18. Vickers AJ, Elkin EB,. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-574
19. Bangma CH, Roobol MJ, Steyerberg EW,. Predictive models in diagnosing indolent cancer. Cancer 2009; 115 (13 Suppl.): 3100-3106
20. Wolters T, Roobol MJ, van Leeuwen PJ, etal. A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 2011; 185: 121-125
21. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A,. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126-131
22. Dall'era MA, Cowan JE, Simko J, etal. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int 2011; 107: 1232-1237
23. Latini DM, Hart SL, Knight SJ, etal. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol 2007; 178 (3 Pt 1): 826-831; discussion 831-2
24. NIH. NIH State-of-the-Science Conference Statement: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer 2012: 1-17
25. Fradet V, Kurhanewicz J, Cowan JE, etal. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology 2010; 256: 176-183
26. Shariat SF, Walz J, Roehrborn CG, etal. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol 2008; 26: 1526-1531
27. Albertsen PC, Hanley JA, Fine J,. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293: 2095-2101
28. Cooperberg MR, Cowan JE, Hilton JF, etal. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol 2011; 29: 228-234